Intrinsic Value of S&P & Nasdaq Contact Us

Estrella Immunopharma, Inc. ESLA NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
41/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Estrella Immunopharma, Inc. (ESLA) has 10 known insider and institutional holders on record. The largest holder is Eureka Therapeutics, Inc. with 25,277,831 shares. Other notable holders include Li Jianwei and TradeUP Acquisition Sponsor LLC.

Over the last 12 months, insiders have made 1 transactions in ESLA stock — 0 buys (valued at RSU Award) and 0 sells (valued at RSU Award).

ESLA Insider Ownership

Top Holder
Eureka Therapeutics, Inc.
25,277,831 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
12-Month Transaction Activity
Buy 0%
Sell 0%
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Eureka Therapeutics, Inc. 10 Percent Owner 25,277,831 2023-10-10
100%
2 Li Jianwei Co-chief Executive Officer 1,253,730 2022-03-17
5%
3 Tradeup Acquisition Sponsor Llc 10 Percent Owner 1,145,760 2021-07-22
5%
4 Liu Cheng Chief Executive Officer 490,796 2025-02-14
2%
5 Xu Jiandong Chief Financial Officer 490,796 2025-02-14
2%
6 Owl Creek Asset Management, L.p. Director 255,000 2023-01-09
1%
7 Zhang Hong Other: Chairperson of the Board 240,481 2024-08-23
1%
8 Twigg Weston Director 10,000 2021-07-22
0%
9 Long James Director 10,000 2021-07-22
0%
10 Jiang Tao Director 10,000 2021-07-26
0%
Recent Transactions (last 12 months)
Date Name Role Type Shares Price Value
2025-09-22 Jia Dengyao Director Unknown - - -
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message